BamSEC and AlphaSense Join Forces
Learn More

Sagimet Biosciences Inc. – Indentures

NASDAQ: SGMT    
Share price (11/6/26): $9.85    
Market cap (11/6/26): $695 million

Indentures Filter

EX-4.1
from 8-K 14 pages The Issuer Has Filed a Registration Statement (Including a Prospectus) With the SEC for the Offering to Which This Communication Relates. Before You Invest, You Should Read the Prospectus in That Registration Statement and Other Documents the Issuer Has Filed With the SEC for More Complete Information About the Issuer and This Offering. You May Get These Documents for Free by Visiting Edgar on the SEC Web Site at WWW.SEC.GOV. Sagimet Biosciences Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.6
from S-3 38 pages Sagimet Biosciences Inc. Indenture Dated as of [ · ], 20[ · ] [ · ] Trustee
12/34/56
EX-4.3
from 10-K 3 pages Description of Capital Stock
12/34/56
EX-4.2
from S-1 2 pages Indenture or similar
12/34/56
EX-4.1
from S-1 2 pages ★ D El Awa R E ★ S Seal Agimet Biosciences in C. Corporate December 19, 2006 Cs-A-Fully Paid and Nonassessable Shares of Series a Common Stock, $0.0001 Par Value Per Share, of Sagimet Biosciences Inc. Transferable on the Books of the Corporation in Person or by Duly Authorized Attorney Upon Surrender of This Certificate Properly Endorsed. This Certificate Is Not Valid Until Countersigned by the Transfer Agent and Registered by the Registrar. Witness the Facsimile Seal of the Corporation and the Facsimile Signatures of Its Duly Authorized Officers. Dated: This Certifies That Is the Record Holder of Incorporated Under the Laws of the State of Delaware Countersigned and Registered: American Stock Transfer & Trust Company, LLC (Brooklyn, Ny) Transfer Agent and Registrar By: Authorized Signature Chief Executive Officer General Counsel & Chief Compliance Officer Cusip 786700 10 4 See Reverse for Certain Definitions and Legends
12/34/56
EX-4.2
from S-1 41 pages Sagimet Biosciences Inc. Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.2
from DRS 41 pages Sagimet Biosciences Inc. Amended and Restated Investors’ Rights Agreement
12/34/56